SLE和pSS中ILC2与ILC3的Fas表达升高与干扰素特征相关
研究采用流式细胞术检测SLE(n=20)、pSS(n=20)和健康对照(n=17)外周血ILC亚群及pDC频率与表型,并按I型IFN特征分层。结果显示SLE患者ILC1频率升高,pSS中ILC1频率与疾病活动度相关;高I型IFN特征患者ILC2和ILC3上Fas表达升高,伴血中这些细胞频率降低。
要点
- SLE患者外周血ILC1频率较健康对照升高。
- pSS患者ILC1频率与疾病活动度相关。
- 高I型IFN特征者ILC2/ILC3的Fas表达升高且血中频率降低。
核心结论
- I型IFN特征的存在与SLE和pSS患者循环ILC2和ILC3的Fas表达及频率相关,可能改变ILC的稳态平衡。
研究设计与样本
- 研究纳入SLE患者20例、pSS患者20例和健康对照17例,用流式细胞术评估外周血ILC亚群和pDC的频率与表型。
- 通过循环单核细胞RT-qPCR评估I型IFN特征,将患者按有无IFN特征分层。
主要发现
- SLE患者外周血ILC1频率较健康对照升高,pSS患者ILC1频率与疾病活动度相关。
- SLE、pSS和健康对照之间ILC2或ILC3的总体频率无差异。
- 高I型IFN特征患者ILC2和ILC3上Fas表达升高,同时血中这些细胞频率降低。
临床怎么用
- 对SLE和pSS患者可关注I型IFN特征与ILC2/ILC3的Fas表达及频率的关联,作为理解疾病免疫机制的线索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The role of innate lymphoid cells (ILCs) in the pathophysiology of rheumatic diseases is emerging. Evidence from animal studies implicate type I IFN, produced by plasmacytoid dendritic cells, to be involved in regulating the survival of group 2 and group 3 ILCs (ILC2s and ILC3s) via the upregulation of Fas (CD95) expression. For the first time, we explored the frequency and phenotype of circulating ILCs in SLE and primary Sjögren's syndrome (pSS) in relationship to the IFN signature. METHODS: Frequencies and phenotypes of ILC subsets and plasmacytoid dendritic cells were assessed by flow cytometry in peripheral blood of patients with SLE (n = 20), pSS (n = 20) and healthy controls (n = 17). Patients were stratified by the presence or absence of an IFN signature as assessed by RT-qPCR on circulating mononuclear cells. RESULTS: ILC1 frequencies were increased in peripheral blood of patients with SLE as compared with healthy controls and correlate with disease activity in pSS patients. Overall, the frequencies of ILC2s or ILC3s did not differ between patients with SLE, pSS and healthy controls. However, patients with a high type I IFN signature expressed elevated levels of Fas on ILC2s and ILC3s, which coincided with decreased frequencies of these cells in blood. CONCLUSION: The presence of a type I IFN signature is related to Fas expression and frequencies of circulating ILC2s and ILC3s in patients with SLE and pSS, potentially altering the homeostatic balance of ILCs.
引用
- Blokland SLM, van den Hoogen LL, Leijten EFA, et al. Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren's syndrome. Rheumatology (Oxford). 2019. PMID: 31220315. doi:10.1093/rheumatology/kez116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。